MeƱoza, Bb Boy 1 .
HRN: 21-99-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2023
CEFTRIAXONE 1G (VIAL)
05/03/2023
05/10/2023
IV
280mg
OD
Sepsis
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: PneumoniaCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes